Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in Relapsed Follicular or Mantle Cell Lymphoma
NCT00856245Phase 2Completed
- Sponsor
- University of Kansas Medical Center
- Start
- Feb 2009
- Primary completion
- Jul 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in follicular lymphoma (FL), mantle cell lymphoma (MCL), sponsored by University of Kansas Medical Center. Started Feb 2009; status: completed.
02
Drugs
rituximab
03
Conditions
follicular lymphoma (FL)mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT00856245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00856245.